These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 16807905)
1. Vanishing white matter disease: a review with focus on its genetics. Pronk JC; van Kollenburg B; Scheper GC; van der Knaap MS Ment Retard Dev Disabil Res Rev; 2006; 12(2):123-8. PubMed ID: 16807905 [TBL] [Abstract][Full Text] [Related]
2. Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Leegwater PA; Vermeulen G; Könst AA; Naidu S; Mulders J; Visser A; Kersbergen P; Mobach D; Fonds D; van Berkel CG; Lemmers RJ; Frants RR; Oudejans CB; Schutgens RB; Pronk JC; van der Knaap MS Nat Genet; 2001 Dec; 29(4):383-8. PubMed ID: 11704758 [TBL] [Abstract][Full Text] [Related]
3. [From gene to disease; a defect in the regulation of protein production leading to vanishing white matter]. Pronk JC; Leegwater PA; van der Knaap MS Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1933-6. PubMed ID: 12404908 [TBL] [Abstract][Full Text] [Related]
4. The spectrum of mutations for the diagnosis of vanishing white matter disease. Scali O; Di Perri C; Federico A Neurol Sci; 2006 Sep; 27(4):271-7. PubMed ID: 16998732 [TBL] [Abstract][Full Text] [Related]
5. Dominant form of vanishing white matter-like leukoencephalopathy. Labauge P; Fogli A; Castelnovo G; Le Bayon A; Horzinski L; Nicoli F; Cozzone P; Pagès M; Briere C; Marty-Double C; Delhaume O; Gelot A; Boespflug-Tanguy O; Rodriguez D Ann Neurol; 2005 Oct; 58(4):634-9. PubMed ID: 16047349 [TBL] [Abstract][Full Text] [Related]
6. The large spectrum of eIF2B-related diseases. Fogli A; Boespflug-Tanguy O Biochem Soc Trans; 2006 Feb; 34(Pt 1):22-9. PubMed ID: 16246171 [TBL] [Abstract][Full Text] [Related]
7. Cree leukoencephalopathy and CACH/VWM disease are allelic at the EIF2B5 locus. Fogli A; Wong K; Eymard-Pierre E; Wenger J; Bouffard JP; Goldin E; Black DN; Boespflug-Tanguy O; Schiffmann R Ann Neurol; 2002 Oct; 52(4):506-10. PubMed ID: 12325082 [TBL] [Abstract][Full Text] [Related]
8. Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases. Labauge P; Horzinski L; Ayrignac X; Blanc P; Vukusic S; Rodriguez D; Mauguiere F; Peter L; Goizet C; Bouhour F; Denier C; Confavreux C; Obadia M; Blanc F; de Sèze J; Fogli A; Boespflug-Tanguy O Brain; 2009 Aug; 132(Pt 8):2161-9. PubMed ID: 19625339 [TBL] [Abstract][Full Text] [Related]
9. Vanishing white matter disease associated with progressive macrocephaly. Pineda M; R-Palmero A; Baquero M; O'Callaghan M; Aracil A; van der Knaap M; Scheper GC Neuropediatrics; 2008 Feb; 39(1):29-32. PubMed ID: 18504679 [TBL] [Abstract][Full Text] [Related]
11. Leukoencephalopathy with vanishing white matter: a review. Bugiani M; Boor I; Powers JM; Scheper GC; van der Knaap MS J Neuropathol Exp Neurol; 2010 Oct; 69(10):987-96. PubMed ID: 20838246 [TBL] [Abstract][Full Text] [Related]
12. Identification of ten novel mutations in patients with eIF2B-related disorders. Ohlenbusch A; Henneke M; Brockmann K; Goerg M; Hanefeld F; Kohlschütter A; Gärtner J Hum Mutat; 2005 Apr; 25(4):411. PubMed ID: 15776425 [TBL] [Abstract][Full Text] [Related]
13. Arg113His mutation of vanishing white matter is not present in multiple sclerosis. Lucas M; Suarez R; Marcos A; Solano F; Venegas A; Garcia-Sanchez MI; Ortiz L; Izquierdo G Mult Scler; 2007 Apr; 13(3):424-7. PubMed ID: 17439913 [TBL] [Abstract][Full Text] [Related]
14. Leucoencephalopathy with vanishing white matter may cause progressive myoclonus epilepsy. Jansen AC; Andermann E; Niel F; Creveaux I; Boespflug-Tanguy O; Andermann F Epilepsia; 2008 May; 49(5):910-3. PubMed ID: 18266750 [TBL] [Abstract][Full Text] [Related]
15. Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. van der Knaap MS; Leegwater PA; Könst AA; Visser A; Naidu S; Oudejans CB; Schutgens RB; Pronk JC Ann Neurol; 2002 Feb; 51(2):264-70. PubMed ID: 11835386 [TBL] [Abstract][Full Text] [Related]
16. Regulation of protein synthesis in lymphoblasts from vanishing white matter patients. van Kollenburg B; Thomas AA; Vermeulen G; Bertrand GA; van Berkel CG; Pronk JC; Proud CG; van der Knaap MS; Scheper GC Neurobiol Dis; 2006 Mar; 21(3):496-504. PubMed ID: 16185887 [TBL] [Abstract][Full Text] [Related]
17. [Natural history of adult-onset eIF2B-related disorders: a multicentric survey of 24 cases]. Carra-Dalliere C; Horzinski L; Ayrignac X; Vukusic S; Rodriguez D; Mauguiere F; Peter L; Goizet C; Bouhour F; Denier C; Confavreux C; Obadia M; Blanc F; de Seze J; Sedel F; Guennoc AM; Sartori E; Laplaud D; Antoine JC; Fogli A; Boespflug-Tanguy O; Labauge P Rev Neurol (Paris); 2011 Nov; 167(11):802-11. PubMed ID: 21676421 [TBL] [Abstract][Full Text] [Related]
18. Adult-onset vanishing white matter leukoencephalopathy presenting as psychosis. Denier C; Orgibet A; Roffi F; Jouvent E; Buhl C; Niel F; Boespflug-Tanguy O; Said G; Ducreux D Neurology; 2007 May; 68(18):1538-9. PubMed ID: 17470759 [No Abstract] [Full Text] [Related]
19. [Eukaryotic translation initiation factor 2B and leukoencephalopathy with vanishing white matter]. Pan YX; Wu Y; Niu ZP; Jiang YW Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):608-10. PubMed ID: 19829687 [TBL] [Abstract][Full Text] [Related]